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Abstract
Background: Disease progression in the absence of therapy varies significantly in HIV-1 infected individuals. Both
viral and host cellular molecules are implicated; however, the exact role of these factors and/or the mechanism
involved remains elusive. To understand how microRNAs (miRNAs), which are regulators of transcription and
translation, influence host cellular gene expression (mRNA) during HIV-1 infection, we performed a comparative
miRNA and mRNA microarray analysis using PBMCs obtained from infected individuals with distinct viral load and
CD4 counts.
Methods: RNA isolated from PBMCs obtained from HIV-1 seronegative and HIV-1 positive individuals with distinct
viral load and CD4 counts were assessed for miRNA and mRNA profile. Selected miRNA and mRNA transcripts were
validated using in vivo and in vitro infection model.
Results: Our results indicate that HIV-1 positive individuals with high viral load (HVL) showed a dysregulation of 191
miRNAs and 309 mRNA transcripts compared to the uninfected age and sex matched controls. The miRNAs miR-
19b, 146a, 615-3p, 382, 34a, 144 and 155, that are known to target innate and inflammatory factors, were
significantly upregulated in PBMCs with high viral load, as were the inflammatory molecules CXCL5, CCL2, IL6 and
IL8, whereas defensin, CD4, ALDH1, and Neurogranin (NRGN) were significantly downregulated. Using the
transcriptome profile and predicted target genes, we constructed the regulatory networks of miRNA-mRNA pairs
that were differentially expressed between control, LVL and HVL subjects. The regulatory network revealed an
inverse correlation of several miRNA-mRNA pair expression patterns, suggesting HIV-1 mediated transcriptional
regulation is in part likely through miRNA regulation.
Conclusions: Results from our studies indicate that gene expression is significantly altered in PBMCs in response to
virus replication. It is interesting to note that the infected individuals with low or undetectable viral load exhibit a
gene expression profile very similar to control or uninfected subjects. Importantly, we identified several new mRNA
targets (Defensin, Neurogranin, AIF) as well as the miRNAs that could be involved in regulating their expression
through the miRNA-mRNA interaction.
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Background
HIV-1 infected individuals show remarkable variation in
virus replication and disease progression [1,2]. Recent
studies support the notion that the host cellular gene ex-
pression profile (the transcriptome), in the context of
virus infection, is directly correlated with disease pat-
terns [3-5]. The gene expression pattern associated with
HIV-1 infection in cells is likely controlled by host gen-
etics and external factors, leading to dysregulated anti-
viral activity, inflammatory response and disease
progression. The replication, spread, and immune eva-
sion of the virus and the progression of disease depend
on host cellular transcription and gene regulation in
virus-specific target cells and bystander cells [6-8]. As
virus replication is dependent on host cellular machin-
ery, high viral load (HVL) augments cell destruction and
gene regulation, whereas low viral load (LVL) or un-
detectable viral load promotes latency and possibly im-
mune control. Further, increased virus production also
results in release of free extracellular (cell- and virus-
free), virion-associated, and cell-associated viral antigens,
as well as infectious and noninfectious virus particles
that could potentially alter bystander cell transcriptome
and destruction. Consistent with this scenario, HIV-1
virus with defective expression of viral proteins such as
Nef, Vpr, Gag, and Pol is shown to induce differential
gene expression [9-11].
Host factors bearing on the outcome of HIV-1 infec-
tion include genetic elements such as HLA alleles, poly-
morphisms in HIV-1 receptors and coreceptors, and
genes involved in innate and adaptive immune responses
[12-15]. Following the landmark discovery of the CCR5-
Δ32 mutation that protects against HIV-1 infection
[16-18], many other genetic variants have been shown to
affect HIV-1 infection and AIDS pathogenesis [12,19,20].
It is likely that, in addition to incomplete immunological
control, host genetic variation and differences in gene
expression in the infected host cells may also contribute
to the differential disease pattern [21-23]. Along these
lines, attempts were made to identify host cellular pro-
teins associated with HIV-1 infection [24-27]. There is
limited information, however, regarding the regulation of
host cellular genes at the transcriptional, post-
transcriptional, and translational levels.
Previous studies have shown that HIV-1 infection dif-
ferentially regulates host cellular factors responsible for
inflammation, immune response, cell cycle/proliferation
and apoptosis, suggesting that differential gene expres-
sion in infected individuals either accelerates disease
progression or enhances resistance to the development
of disease [28-30]. Recent discoveries have emphasized a
central role for the new class of small non-coding RNA
in gene expression controlling growth, development, and
immune response in vivo [31-33]. Regulation of gene
expression by miRNA occurs primarily at the post-
transcriptional level [34,35]. Recent studies have shown
that miRNA have a unique expression profile in cells of
the innate and adaptive immune systems, CNS, and
cancers [36-39]. Based on these observations, we
hypothesize that pathogens including viruses could po-
tentially modulate host cellular transcription at multiple
levels by targeting various factors including miRNAs.
Studies previously have evaluated the expression of
either miRNA or mRNA using PBMCs, CD4+ T-
lymphocytes, CD8+ T-lymphocytes, monocytes and/or
brain tissue from HIV-1 infected subjects [4,40-48]. Re-
sults from these studies have identified a number of cell
specific miRNAs that are differentially regulated by HIV-
1 infection. Similarly regulated mRNA transcripts
targeting IFN, cytokine-cytokine receptor signaling,
apoptosis and MAPK signaling were also regulated by
HIV-1 infection. However, in the case of HIV-1 infec-
tion, few combined miRNA and mRNA analyses using
RNA isolated from the same sample or at the same time
point have been conducted, except for the recent studies
by Zhou et al [49] and Chang et al [50], using HIV-1
subjects brain tissue and infected CD4+ T cells, respect-
ively. These studies provided the first line of evidence
for a functional relationship between miRNA and
mRNA in the context of HIV-1. In an effort to under-
stand miRNA-mRNA interactions in the host during
HIV-1 infection, we performed comparative global
miRNA and mRNA microarray profiling in PBMCs de-
rived from HIV-1 infected individuals with high and low
or undetectable viral load and compared these with age
and sex matched uninfected controls. Our results indi-
cate that individuals with high viral load showed signifi-
cant differences in both their miRNA and mRNA
profiles compared to subjects with low viral load. In
HIV-1 positive subjects with >45,000 copies/ml of viral
RNA, a high proportion of miRNAs (178/191) showed
increased expression (with >2-fold change, p value of
<0.05), whereas the mRNA profile showed opposing re-
sults with a higher number of genes (184/308) being
downregulated. The regulatory network analysis revealed
that several host cellular factors, implicated in HIV-1
disease progression, might be modulated through
miRNA regulation of gene expression during disease de-
velopment. Taken together, these results provide evi-
dence that the miRNA profile could be an early
indicator of HIV-1 induced host cellular dysfunction.
Results
miRNA profiling in control versus HIV-1 positive groups
RNA isolated from HIV-1 subjects with high and low
viral loads, and from control subjects were subjected to
miRNA profiling and data analyses to identify the differ-
entially expressed miRNA within these groups. RNA
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isolated from PBMCs was tested for RNA quality and
integrity by Bioanalyzer and by Taqman assays for
endogenous control miRNAs and mRNA species. Specif-
ically, the samples were tested for RNU48, miR-26b, or
U6, and assessed by the absolute Ct value of <25. The
expression profile of 754 host cellular miRNAs (exclud-
ing endogenous controls) was assessed in PBMCs
obtained from HIV-1 negative and HIV-1 positive sub-
jects. Results from high and low viral load groups were
compared with the uninfected control group as well as
within the HIV-1 positive groups. Differentially regulated
miRNAs between these groups were analyzed using two
different software packages with the appropriate settings
required for each software to maximize the confidence.
The first program used was DataAssist with default set-
tings (maximum allowable Ct value was 40), as sug-
gested by the manufacturer. The Benjamini-Hochberg
False Discovery Rate adjustment was applied for multiple
comparison corrections. Our results indicate that 38,
244 and 183 miRNAs were differentially regulated in
control versus LVL, control versus HVL, and LVL versus
HVL respectively, with at least a 2-fold change and p
value <0.05 (Table 1).
For the StatMiner analysis, miRNAs that show a raw
Ct value of <36, and miRNAs that are expressed
in >25% of the subjects in each group, were included as
suggested [51]. This resulted in the elimination of 177,
173 and 160 miRNAs from each comparison (control vs
LVL; Control vs HVL; LVL vs HVL) respectively. The
remaining miRNA were assessed using a statistical pack-
age to identify the significantly regulated miRNA within
and between these groups. Our results indicate that
HIV-1 infection differentially regulated expression of
several miRNAs (+/- 1.72-fold with p < 0.05 using the
Benjamini-Hochberg method within each group (Add-
itional file 1: Table S1)). The level of expression in
infected subjects was compared with that in uninfected
controls, and fold differences were calculated based on
normalization with endogenous control, U6 snRNA/
mammU6, as suggested by the manufacturer. Our re-
sults indicate that 41, 218 and 182 miRNAs were differ-
entially regulated with +/- 2-fold change and p < 0.05 in
control versus LVL, control versus HVL and LVL versus
HVL, respectively (Table 1). To further increase the
confidence, miRNAs that were identified as differentially
regulated by both programs were assessed, and 21, 191
and 158 of miRNAs were commonly found in both ana-
lyses (p < 0.05) of control versus LVL, control versus
HVL and LVL versus HVL, respectively. However, as the
significance increases to p < 0.01 both analyses identified
more than 70% of miRNAs commonly.
Differential regulation of miRNA in HIV-1 subjects with a
broad range of viral load and CD4 counts
Among the 754 miRNAs tested, 21 miRNAs were differ-
entially regulated in low viral load individuals compared
to uninfected controls using two different softwares
(Table 1). Of these, 2 miRNAs were downregulated and
19 miRNAs were upregulated (fold change ranging from
3.09 to 20.48). However, in the HVL group, the number
of differentially regulated miRNAs was significantly
higher. A total of 191 miRNAs were differentially regu-
lated in HVL subjects compared to uninfected controls.
Of these, 13 were downregulated (fold change ranging
from -2.05 to -89.82) and 178 were upregulated. Simi-
larly, we identified 158 miRNAs that were differentially
regulated when we compared the LVL and HVL groups.
Of these, 27 miRNAs were downregulated and 131
miRNAs were upregulated, with the fold change ranging
from 1.73 to 6460.41. Together these results indicate
that HIV-1 infection upregulated expression of several
miRNAs and the effect was more significant in high viral
load group compared to low viral load group.
Figure 1A shows the miRNAs that are specific to
each group, as well as the overlap between the groups.
When uninfected controls (CT) are compared with HIV-1
infected samples, 17 miRNAs are commonly dysregulated in
the HIV-1 infected subjects (LVL and HVL combined).
Among the 21 miRNAs that are differentially regulated be-
tween the CT vs. LVL groups, 3 were unique to the LVL
group, whereas when the CT and HVL groups are com-
pared, 62 of the 191 differentially regulated miRNAs
were specific to the HVL group. Similarly, we also com-
pared all three groups and found that 4 miRNAs are
commonly dysregulated in all three groups. Further
examination indicates that miR-1275, miR-483-5p, and
miR-650 show similar upregulation in the HVL group
compared to either the CT or LVL group, whereas
Table 1 Differentially regulated miRNA in low and high viral load groups compared to uninfected control group using
two different software with statistical significance
Differentially regulated miRNA+/- 2-fold p < 0.05 Differentially regulated miRNA+/- 2-fold p < 0.01
DataAssist StatMiner Common DataAssist StatMiner Common
Controlvs. LVL 38 41 21 8 14 8
Controlvs. HVL 244 218 191 163 137 118
LVL vs. HVL 183 182 158 90 99 80
Comparative analysis of significantly differentially regulated miRNAs between Statminer (Integromics) and DataAssist (Applied Biosystems). For both analyses,
RNU44, RNU48, and ath-miR-159 controls were eliminated from the analysis. For DataAssist, all miRNAs with CT valve of <40 were considered.
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miR-1262 shows downregulation in the CT versus HIV-
1 positive group, and was upregulated in the HVL
group compared to the LVL group. Further analyses
within the HVL group based on viral load ranging from
40,000 to 600,000 RNA copies/ml did not show any
additive effect. Together, these results suggest that
HIV-1 infection has specific regulatory effects on
miRNA expression profiles.
To further assess the clustering of subjects within
these groups and across the groups, hierarchical cluster-
ing was performed in a comparison of the control and
LVL groups (Figure 1B) and of the control and HVL
groups (Figure 1C). When the control and LVL groups
are compared, subjects from each group formed several
clusters and these clusters dispersed intermittently.
Many of the control samples formed a single major clus-
ter, while the remaining control samples were inter-
spersed among the LVL subjects in two other major
clusters. However, when we compared the control and
HVL groups (Figure 1C), the majority of the subjects
from each group clustered distinctly from each other
based on their miRNA profile, with an exception of a
single separate cluster of HVL containing 4 subjects and
control group with 6 subjects from each group. Further
analyses of CD4 counts, age and viral load did not show
any differences compared to subjects in the major
cluster. The comparison of HVL to LVL produced 3
major clusters in LVL and 2 clusters in HVL (Additional
file 2: Figure S1). Importantly, these results suggest that
the miRNA expression profile within the infected sub-
jects with high viral load is specific. This pattern is dif-
ferent in HIV-1 subjects with undetectable viral load
and high CD4 counts, who maintain an expression pro-
file that is similar to uninfected controls. More import-
antly, this distinct profile is observed in most of the
subjects (based on the clustering) and further confirms
the specificity.
Validation of miRNA expression by qRT-PCR
To validate the differentially regulated miRNAs from the
microarray results, we randomly selected miRNAs
(miRNAs with >2-fold change and p < 0.05) and tested
them in independent subjects (using similar selection
criteria) by qRT-PCR using miRNA specific Taqman
primers and probes (Figure 2A&B). Results from the
comparison of the LVL group and uninfected controls
indicate that among the miRNAs tested, six miRNAs
(miR-483-5p, miR-16, miR-18b*, miR-376b, miR-938,
and miR-1260) exhibit similar fold change pattern
as seen in the high throughput results. However, three
miRNAs (miR-21*, miR-1262 and miR-1303) showed
an opposite fold change pattern to that of the
Figure 1 A: Expression profile of differentially regulated miRNAs in HIV-1 infected versus uninfected subjects. (A) The Venn diagram
displays the number and overlap of significantly differentially expressed miRNA (Benjamini-Hochberg adjusted, p < 0.05) among the LVL and HVL
groups relative to the CT and within the infected groups. Hierarchical clustering of miRNA between CT and LVL (B); and CT and HVL (C).
MicroRNA in the clustergram are dysregulated at a significance cutoff of p < 0.05. The dendogram depicting the clustering of samples is
calculated using Complete linkage with Euclidian distance measure values. Color ranging from green to red indicates minimum to maximum
ΔCT. Numbers on X-axis represent subject group. CT, uninfected controls; LVL, low viral load subjects; HVL, high viral load subjects. The
clustergrams were generated using StatMiner analyses.
Duskova et al. BMC Infectious Diseases 2013, 13:250 Page 4 of 18
http://www.biomedcentral.com/1471-2334/13/250
high throughput results. Specifically, miR-1262 was
downregulated and miR-21* and miR-1303 were
upregulated in high throughput, while in the qRT PCR,
they were upregulated and downregulated, respectively
(Figure 2A). Overall these results indicate about 60% val-
idation (6/9) in terms of similar state of expression (up
or down) in both the high throughput array and qRT-
PCR, however the exact fold change level is different be-
tween the two systems as expected.
Similarly, we also tested randomly selected miRNAs in
a set of independent HVL subjects relative to uninfected
controls (Figure 2B). This comparison indicated that
among the seven miRNAs tested, miR-1303, miR-516b
and miR-564 showed upregulation in both high through-
put array and qRT-PCR, whereas miR-144 and miR-935
showed downregulation in both the array and qRT-PCR
assay (Figure 2B). However, two miRNAs (miR-21* and
miR-18b*) showed no correlation between the two as-
says. Further analysis indicates that both miR-21* and
miR-18b are low abundant miRNAs and that could be
one of the reasons for the observed discrepancies. Over-
all, validation of miRNA in both sample groups confirms
>65-85% of the miRNAs suggesting that the array results
are reproducible in independent subjects and this effect
is more pronounced in the HVL group compared to
LVL group. These results are in accordance with the
published studies [52-54], indicating that there are dif-
ferences in differential regulation observed in array ver-
sus qRT-PCR assay and 100% validation is rare if the
validation samples are randomly selected as done here.
This is further supported when we assessed the signifi-
cance level (p values) and the fold change for these
miRNAs (in Additional file 3: Table S2). For instance miR-
1303 is upregulated in both LVL and HVL subjects in
the array, however the significance is p = 0.024 in LVL
subjects and p = 4.67E-13 in HVL subjects. Validation re-
sults for miR-1303 by qRT-PCR show similar trend in
HVL and opposite pattern in LVL subjects. Additionally,
we also observed that five miRNAs that are in concord-
ance with qRT-PCR have highly significant p values
(<1.35E-05), whereas that of the miRNAs tested in LVL
are <0.05 – 0.005. Together these results suggest that dif-
ferentially regulated miRNAs with significant p values
(<0.00001) has higher validation concordance rate than
miRNAs selected based on higher fold change.
HIV-1 induced gene regulation of cellular mRNA
transcripts
MicroRNAs regulate cellular gene expression at the post-
transcriptional level, thus silencing and/or downregulating
gene expression [55,56]. To assess whether a direct correl-
ation exists between the expression patterns of miRNA
and mRNA, we assessed the expression profile of mRNA
transcripts in PBMCs of the same subjects. Microarray
profiling of mRNA samples was normalized with the in-
ternal endogenous control and cross-compared between
the two groups. Among the 47,000 transcripts tested,
21,852 probes were detected in all samples. Among the
total detected probes, 47, 11,510 and 10,007 probes were
significantly (p < 0.01) regulated but less than +/- 2-fold
change in control versus LVL, control versus HVL and
LVL versus HVL groups, respectively. However, when
we narrowed the probes with a fold change of +/- 2-
(p < 0.01), we obtained 0, 309 and 182 probes in the 3
groups, respectively (Table 2).
Among the 47 probes (41 annotated) differently
expressed in the LVL samples compared to CT (FDR
corrected with p-value of <0.01), 36 were upregulated
Figure 2 Independent individual validations of randomly selected differentially regulated miRNAs from Taqman array platform. qRT-
PCR was used to validate the expression of selected miRNAs from the high throughput results (derived by StatMiner) using a specific primer and
probe for each miRNA. (A) miRNAs selected from Control versus LVL comparison; (B) miRNAs selected from control versus HVL comparison. Fold
increase/decrease was calculated based on normalization to U6. Average fold change for each miRNA represents fold change obtained from
independent donors (N = 5 per group).
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and 11 were downregulated (Table 2). None of the tran-
scripts show more than 1 fold difference (p < 0.01) com-
pared to controls, suggesting that there is not a greater
difference between uninfected controls and infected sub-
jects with an undetectable viral load. In contrast, 309
probes were differentially regulated in the high viral
load samples compared to the uninfected controls
(FDR corrected with a p-value of <0.01 with +/- 2-fold
regulation). Of these, 125 were upregulated, and 184
were downregulated. Similarly, we also compared the
LVL and HVL groups and identified 182 probes that
are differentially regulated. Within these transcripts, a
majority (2/3) of them (113) are downregulated and 69
were upregulated. Further, 178 probes were commonly
shared between control versus HVL and LVL versus
HVL, whereas none of the mRNAs are shared by all the
groups or between control versus LVL group. More im-
portantly, the remaining 131 probes are very specific to
the HVL group. Together, these results suggest that
subjects with high viral load or AIDS exhibit a unique
transcriptome profile compared to the low viral load
group. Similar findings were observed in other studies
[4,42,44,45]. Clustergram analysis of differentially regu-
lated mRNA profiles between control and LVL did not
show distinct clustering (Figure 3A), whereas the con-
trol versus HVL group comparison showed clusters
segregating distinctly, indicating a different transcrip-
tome profile mediated by virus replication within
this group (Figure 3B). Similar comparison between
LVL and HVL also exhibited a distinct clustering
Table 2 Differentially regulated mRNA probes in low and high viral load groups compared to uninfected control group
with statistical significance
Detected mRNA probes p ≤0.01
(All probes)
p ≤0.01
(Known probes)
+/- 2 fold and p ≤ 0.01
(All probes)
+/- 2 fold and p ≤ 0.01
(Known probes)
Control Vs. LVL 21,852 47 41 0 0
Control Vs. HVL 11,510 9,137 309 280
LVL Vs. HVL 10,007 7,820 182 166
Differentially regulated mRNA probes in within the three study groups based on Illumina HT12 microarray data analyzed with IBD. All probes represent annotated,
non-annotated, and curated probes. Known probes represent annotated probes or named genes.
Figure 3 Expression profile of differentially regulated mRNA transcripts in HIV-1 infected versus uninfected subjects. (A). Hierarchical
clustering of differentially regulated mRNA in LVL compared to control; and (B), CT and HVL. The probes in this clustergram are significantly
differentially regulated (p < 0.05). Red indicates high, blue indicates low, and gray stands for no change in level of expression. Numbers on X-axis
represent subject group; Y-axis represents the gene symbol. CT, uninfected controls; LVL, low viral load subjects; HVL, high viral load subjects.
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pattern (Additional file 4: Figure S2) suggesting that virus
replication has significant impact on host cellular gene
expression.
Host cellular factors, pathways and biological processes
altered by HIV-1
Next, we analyzed these mRNA transcripts using the
STRING and DAVID databases, to identify the biochem-
ical pathways in which they are involved. A comparison
of the differentially regulated transcripts in LVL group
compared to control group did not show significant
changes in cellular pathways, whereas a comparison
of the control and HVL groups exhibits distinct
pathway regulation (Figure 4A). Though the network
shows several interaction groups, four major clusters
were apparent; this includes cluster 1 (chemokines and
its receptors), cluster 2 (proinflammatory cytokines),
cluster 3 (Interferon induced genes) and cluster 4
(metallothionein genes). Among these clusters, the most
significantly regulated molecules comprise inflammatory
factors, cytokines/chemokine, cell cycle and apoptosis
related proteins, cell signaling molecules, factors
expressed in response to virus/bacterial infection, innate
factors and cell-to-cell interaction molecules. Most
importantly, many of the inflammatory factors and
cytokines (CXCL5, CCL2, CCL8, CXCL10, CCL7, IL1α,
IL-1β, IL6 and IL8) are upregulated in the HVL group,
whereas antiviral factors and innate immune molecules
(members of the defensin family, AIF) were significantly
downregulated (Additional file 3: Table S2).
We next assessed the functionality of the significantly
dysregulated genes with a focus on those genes that were
statistically over represented. An analysis of biological
functions, using Gene Ontology Enrichment, shows only
four significant functions, including response to virus,
IFNγ mediated signaling, immune response, and cellular
component movement, for the comparison between LVL
and controls (Figure 4B). This contrast with the 34
Figure 4 Predicted interaction networks of genes significantly dysregulated in HVL compared to Control. (A) The interactions between
genes were identified using STRING software. Colored lines indicate different sources of evidence for each interaction. Circles highlight the
predominant clusters within the network. (B & C) Gene Ontology Enrichment analysis for biological processes using significantly differentially
regulated genes in LVL and HVL groups in comparison with CT group. Genes that are differentially regulated in LVL group relative to the CT
yielded 4 significant terms for biological processes (B), while those that are differentially regulated in HVL with respect to CT yielded 34 (C). Bar
graphs are generated using average –lop of p value for each term on y-axis and term name on x-axis. CT, uninfected control; LVL, low viral load
group; HVL, high viral load group.
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significant functions, including inflammatory response,
chemotaxis, and immune response, produced from the
comparison between HVL and the control group
(Figure 4C). These functions relate mostly to inflamma-
tory response, chemotaxis, cell signaling, cell killing and
immune regulation. In addition to the gene ontology en-
richment, our analyses on host cellular pathways using
Ingenuity Pathway Analysis (IPA) indicate several path-
ways that are distinctly regulated by HIV-1 and high
viral load (Additional file 5: Table S3). Differentially reg-
ulated RNA transcripts from HVL group target primarily
apoptosis and DNA damage pathways (6 out of the top
ten pathways) in accordance with the loss of CD4,
whereas, LVL did not show similar pathways. Overall,
these results suggest that HIV-1 infection resulting in
high viral load alters several genes and cellular processes
related to HIV-1 induced disease progression.
Computational analyses to identify miRNA-mRNA
interactions
MicroRNA binds to the 3’ UTR of the mRNA transcript
and regulates gene expression. A single miRNA can po-
tentially regulate single or multiple mRNA and vice
versa [57,58]. We used GroupMiR [59], a computational
method that integrates miRNA and mRNA expression
profiles with miRNA target prediction databases (which
rely on sequence analysis), to infer interactions between
miRNAs and their target mRNAs. This approach of
combining expression and sequence analysis has been
shown to reduce the number of false positives in miRNA
target prediction. These analyses identified 204 miRNAs
and 267 mRNAs, plus 572 possible combination pairs
with a score ranging from 0.1004 to 0.9832. The data
were used to generate the entire interactome presented
in Additional file 6: Figure S3. Further analyses with a
few selected pairs indicate that a number of miRNAs
(miR-144, miR-376a, miR-503 and miR-935) target a
cluster of mRNA including chemokines (CCL2, CCL3,
CCL8, IL1β, IL6, PLA2G7, DFNA and members of
metallothionein gene family), that are part of the inflam-
matory response (Figure 5). These results suggest that
multiple miRNAs could potentially target the same
mRNA transcripts with varying strengths (posterior
probabilities). For instance, miR-144 and miR-376a
exhibit a score of >0.6 for the inflammatory gene cluster,
whereas, miR-503 and miR-935 exhibit a score of <0.2
for the same mRNA transcript, indicating difference in
strength of miRNA-mRNA interaction pairs. However, it
is important to note that though the strengths are differ-
ent for these miRNA-mRNA pairs, the inverse
Figure 5 Network of predicted miRNA-mRNA interactions by GroupMiR using results from miRNA and mRNA array and visualized by
Cytoscape. Regression-based method was used to predict the potential miRNA (circles) that actively regulate mRNA (squares). Selected miRNA
(four) were chosen from a list of miRNAs and their targets. Red and green within the mRNA represents up and down regulation, respectively.
Each slice within the circle represents HIV-1 infected subject.
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correlation between the miRNA and mRNA are con-
stant. The four miRNAs shown in Figure 5 are signifi-
cantly downregulated (<2-fold, p < 0.05) in HVL
samples, whereas 47 of the 50 mRNAs are significantly
upregulated (>2-fold, p < 0.05) in HVL subjects. To fur-
ther verify and correlate the significance of these interac-
tions, we selected a number of mRNA and miRNA pairs
and assessed their expression levels. This includes host
cellular genes IL6, NRGN (Neurogranin), AIF1, NCR3,
ALDH1A1, CCL2 and CCL8 as well as the predicted re-
spective miRNAs. The results presented in Table 3 were
derived by comparing the control subjects to HIV-1
positive subjects (LVL and HVL). First we compared the
correlative effects of the miRNA and mRNA in LVL and
HVL groups compared to control group. The selected
mRNA-miRNA pairs showed a significant inverse cor-
relation in their expression pattern, except for CCL8-
miR-512-3p and CCL8-miR-518d-3p (p > 0.05) in
HVL comparisons. Prediction analyses identified that
NRGN could be potentially regulated by 2 miRNA,
whereas CCL2 and CCL8 could be potentially regu-
lated by several miRNAs. Conversely, miR-935 has
potential binding sites in IL6, CCL2 and CCL8
transcripts in the 3’ UTR region. These results high-
light the ability of GroupMiR to accurately predict
interactions with high levels of variations found in
in vivo. However, additional extensive in vitro ana-
lyses, beyond the scope of this manuscript, are re-
quired to confirm these interactions.
Role of CD4 count and viral load on host cellular
transcriptome
To examine whether other factors, besides the presence
of high viral load, are responsible for the differential
miRNA and mRNA profiles, we selected a number of
cellular factors (CCL2, CXCL5, IL6, IL8 and NRGN)
from our predictions and assessed their expression be-
tween the three groups. The presence of high viral load
significantly influences the expression of CCL2, CCL8,
IL6 and IL8, whereas NRGN was inhibited (Figure 6).
HIV-1 infection itself down regulated NRGN expression
as seen in LVL. Similarly, Defensin and AIF1 were also
down regulated by infection and HVL significantly aug-
mented this inhibition (Additional file 3: Table S2). Next,
we assessed whether there is a possible correlation with
CD4 count, nadir CD4 count, viral load, and host
Table 3 Predicted miRNA-mRNA interacting pairs by GroupMiR in comparison with miRNA profiling studies
mRNA-miRNA pairs by GroupMiR Control vs LVL (miRNA) Control vs HVL (miRNA) LVL vs HVL (miRNA)
mRNA miRNA P value Fold Change P value Fold change P value Fold change P value
AIF1 (-2.67) miR-483-5p 0.8026 5.969 0.00410** 17.088 0.000000205** 2.863 0.0125*
AIF1 (-2.67) miR-605 0.9418 1.164 0.871 29.059 0.0000000127** 24.961 0.0000000542**
ALDH1A1 (-2.11) miR-222 0.2438 1.710 0.229 2.558 0.0611 2.856 0.000129**
ALDH1A1 (-2.11) miR-155 0.7276 5.183 0.0570 16.778 0.000103** 3.237 0.000000808**
NCR3 (-2.3) miR-34a 0.1528 1.936 0.547 20.678 0.0000153** 10.681 0.000576**
NCR3 (-2.3) miR-660 0.119 2.276 0.393 6.452 0.00778** 2.835 0.0233*
NRGN (-4.06) miR-210 0.9606 2.931 0.162 10.536 0.000121** 3.591 0.00276**
NRGN (-4.06) miR-564 0.9702 2.467 0.229 11.667 0.00000170** 4.730 0.00307**
IL6 (4.01) miR-144 0.8496 −1.181 0.855 −25.7093 0.00000508** −21.786 0.000241**
IL6 (4.01) miR-376a 0.8812 −1.264 0.697 −2.638 0.0185* −2.088 0.000000797**
IL6 (4.01) miR-935 0.227 −1.706 0.378 −22.431 0.0000000179** −13.141 0.0000135**
CCL2 (4.53) miR-144 0.1506 −1.181 0.855 −25.709 0.00000508** −21.786 0.000241**
CCL2 (4.53) miR-196b 0.1026 2.167 0.121 −1.071 0.898 −2.321 0.00479**
CCL2 (4.53) miR-376a 0.1272 −1.264 0.697 −2.638 0.0185* −2.088 0.000000797**
CCL2 (4.53) miR-503 0.1154 1.624 0.403 −3.256 0.0480* −5.288 0.00788**
CCL2 (4.53) miR-590-3P 0.1122 3.077 0.099 −2.00 0.252 −6.150 0.00000113**
CCL2 (4.53) miR-935 0.1732 −1.706 0.378 −22.431 0.0000000179** −13.141 0.0000135**
CCL8 (5.11) miR-25 0.5172 −1.095 0.878 2.893 0.00117** 3.169 0.00781**
CCL8 (5.11) miR-376a 0.119 −1.264 0.697 −2.638 0.0185* −2.088 0.000000797**
CCL8 (5.11) miR-512-3p 0.1184 −1.508 0.609 3.942 0.0298* 5.950 0.00829**
CCL8 (5.11) miR-518d-3p 0.1302 −1.124 0.892 4.867 0.00491** 5.471 0.00367**
CCL8 (5.11) miR-935 0.4236 −1.706 0.378 −22.431 0.0000000179** −13.141 0.0000135**
Fold changes and p-values for the miRNA and mRNA in infected PBMC compared to the uninfected controls determined by RealTime StatMiner. * = p < 0.05.
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cellular factors (Table 4). As CD4 count is one of the
major determinants of HIV infection and plays a role in
altering the transcriptome profile [4], we performed
Spearman correlations between the CD4 count, nadir
CD4 count, viral load and the signal intensity of each se-
lected transcriptome within the three groups of subjects.
None of the transcripts significantly correlate with either
CD4 count or nadir CD4 count within the uninfected
control group (Table 4; panel A). Within the LVL group,
IL6 and NRGN significantly correlate with CD4 count
(p < 0.01 and p < 0.05) and not with the nadir CD4 count
(Table 4; panel B). In the HVL group, IL8 showed a sig-
nificant correlation with CD4 count (p < 0.05) and nadir
CD4 count (p < 0.001), whereas, IL6 correlated with nadir
CD4 count only (Table 4; panel C). Next, we assessed,
whether the level of viral load within the HVL group is
directly or inversely correlated with host cellular factor
expression, and results indicate that none of the
transcripts significantly correlate with either CD4 count or
nadir CD4 count. Together, these results indicate that cel-
lular factors are significantly altered by viral load exceed-
ing 50,000 copies/ml, however the increase in viral copy
number (>500,000/ml) did not alter the expression pro-
portionately suggesting a threshold effect.
Validation of host cellular factors regulated by HIV-1 at
RNA and protein level
Furthermore, we selected a few mRNAs from the differ-
entially regulated mRNA from Additional file 3: Table
S2 (AIF, CCL2 and IL6) and validated them in independ-
ent HVL donors (Figure 7A). Results indicate that AIF is
downregulated in both the array as well as in qRT-PCR
assay, whereas CCL2 and IL6 qRT-PCR showed an
upregulation, coinciding with the array data. Although
the number of transcripts validated is small, these results
suggest that validation of mRNA between the array and
Figure 6 Expression of selected transcripts among the CT, LVL, and HVL groups. Unpaired Student’s t-test was used to assess significance
between the three groups. (* = p < 0.05, ** = p < 0.01, *** = p < 0.0001). CT, uninfected controls; LVL, low viral load group; HVL, high viral
load group.
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qRT-PCR assay are concordant with each other specially
in transcriptome profiling.
Although, an in vivo validation of serum cytokines and
chemokines as well as other markers is ideal, we evalu-
ated the inflammatory factors at the protein level using
an in vitro experimental culture model. Normal human
primary PBMCs were infected with HIV-1 virus and the
levels of cytokines/chemokines released post infection
were assessed (Figure 7B). Results indicate that HIV-1
infection significantly increased the expression of inflam-
matory factors and it is independent of viral tropism.
Both NL43 and YU2 significantly upregulated the level
of IL6 by 8-fold, CCL2 by 3-fold, and CXCL5 by 4-fold
with a significance of p < 0.05 in multiple donors. How-
ever, the upregulation was about 2.5-fold for CCL8
(p > 0.05) and 8-fold with p < 0.05 for IL8 in NL43
infected PBMCs, whereas it was 3-fold (p > 0.05) in YU2
infected PBMCs. These results exhibit a direct correl-
ation of the mRNA transcript and protein level that
showed upregulation in HIV-1 subjects compared to
control subjects.
We also tested the expression level of NRGN in these
samples by performing qRT PCR. Results indicate that
PBMCs infected with NL43 or YU2 showed significant
downregulation of the NRGN RNA transcript compared
to mock or uninfected control (Figure 7C). To further
confirm the expression of NRGN at the protein level, ex-
pression of NRGN in cell lysates of PBMCs infected with
NL43, YU2 or mock was assessed by immunoblotting
using an anti-NRGN antibody (Figure 7D). PBMCs
infected with NL43 or YU2 showed significant down
regulation of NRGN compared to uninfected or mock-
infected control cells. Further quantitative analysis using
densitometry scanning indicate that the reduction is
>50% in PBMCs infected with NL43 virus, whereas a
>80% reduction was found in PBMCs infected with YU2
virus (Figure 7E). It is not clear why the two different vi-
ruses exhibit different levels of down regulation of
NRGN. One possible explanation could be due to the in-
fectivity level within these cultures, as both macrophages
and CD4+T cells are infected by YU2, whereas, NL43 in-
fects only CD4+ T cells.
Discussion
Obligatory intracellular pathogens, such as viruses, are
known for their ability to manipulate host cells both at
the molecular and cellular levels. Studies have shown
that the host cellular transcriptome is regulated by HIV-
1 infection, as part of the cells’ response to pathogen in-
sult [60,61]. HIV-1 infection results in differential
Table 4 A-C: Spearman correlations between selected transcript signals and CD4 count, Nadir CD4 count, and viral
load control group
CD4 Count Nadir CD4
(A) Control group Transcript Spearman r p-value Spearman r p-value
CCL2 −0.00296 0.986 0.156 0.358
CXCL5 0.0385 0.821 0.101 0.553
IL6 −0.0236 0.877 0.0424 0.799
IL8 0.0234 0.891 0.227 0.176
NRGN −0.186 0.278 −0.172 0.309
CD4 Count Nadir CD4
(B) LVL group Transcript Spearman r p-value Spearman r p-value
CCL2 −0.281 0.133 −0.193 0.283
CXCL5 0.025 0.895 −0.026 0.883
IL6 −0.488 0.006* −0.185 0.304
IL8 −0.219 0.246 −0.143 0.427
NRGN 0.41 0.024* 0.314 0.074
(C) HVL group CD4 Count Nadir CD4 Viral load
Transcript Spearman r p-value Spearman r p-value Spearman r p-value
CCL2 −0.022 0.918 −0.084 0.695 0.202 0.355
CXCL5 −0.277 0.190 −0.367 0.078 0.190 0.385
IL6 −0.324 0.122 −0.414 0.044* −0.199 0.364
IL8 −0.495 0.014* −0.609 0.001** −0.085 0.670
NRGN 0.224 0.292 0.153 0.475 0.143 0.516
Spearman correlations between selected transcripts and CD4 count, Nadir CD4 count, and viral load (where applicable) within the three study groups obtained
from GraphPad Prism software set to produce two-tailed p-value. * = p < 0.05; ** = p < 0.001.
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regulation of specific cellular genes in target cells such
as CD4+ T cells and monocytes/macrophages suggesting
that virus infection alters host cellular proteins either to
evade the immune system and/or for optimal viral repli-
cation. Considering the prominent role played by
miRNA in the regulation of gene expression, we hypoth-
esized that analysis of miRNA in samples from HIV-1
infected individuals may provide information about the
molecular network and correlate with the disease status
in the host. The novel features of our present study are
the following: (i) We have utilized samples from HIV-1
infected hosts characterized for viral load (HVL and
LVL), together with appropriate age matched controls;
(ii) The samples were derived from a large number of
HIV-1 infected subjects; (iii) ours is one of the first
in vivo studies to compare miRNA and mRNA simultan-
eously in PBMCs isolated from a cohort of HIV-1
infected and uninfected subjects. Our results show that
HIV-1 regulates the cellular transcriptome significantly
through miRNAs, resulting in an inverse correlation of
miRNA-mRNA expression. Furthermore, we have also
established that there is an interrelationship between
multiple miRNA and mRNA interactions and vice versa
within the infected individuals.
The majority of miRNAs are transcribed from noncod-
ing DNA, however a number of miRNAs are also known
to be expressed along with mRNA suggesting a specific
role for mRNA regulation [62-64]. Our comparative ana-
lysis of miRNA and mRNA indicate that HIV-1 infection
alters both miRNA and mRNA expression profiles in
HIV-1 infected subjects compared to uninfected con-
trols. However, the dysregulation of both the RNA spe-
cies is less prominent in LVL subjects compared to the
HVL subjects indicating that viral load has a significant
effect. Differentially expressed miRNA between groups
indicates both overlapping and group specific miRNA
expression. For instance, HIV-1 infection independent of
viral load altered expression of only 4 miRNAs, whereas
191 miRNAs are significantly regulated in the high viral
load group compared to uninfected controls. Previous
studies using PBMCs or CD4+ T cells from infected
viremic, elite controllers and multiply exposed
Figure 7 Validation of HIV-1 regulated host cellular factors at the RNA and protein level. (A) Independent validations of randomly selected
differentially regulated mRNAs from transcriptome analyses. qRT-PCR was performed to validate the expression of selected mRNAs using specific
primer and probe pairs. Fold increase/decrease was calculated based on normalization to RPLPO. Average fold change for each mRNA represents
fold change obtained from independent donors (N = 5 per group). (B) Inflammatory factors released by HIV-1 infected PBMC compared to
uninfected control cells. Expression of CCL2, CCL8, CXCL5, IL6 and IL8 was monitored by ELISA in supernatants obtained from PBMCs infected
with CXCR4-coreceptor utilizing virus (NL43), CCR5-coreceptor utilizing virus (YU2) or mock infected PBMCs (n = 7). * = p < 0.05; NS, Not significant.
(C) Expression level of NRGN transcript in PBMCs infected with NL43, YU2 or mock infected cells. Post infection, RNA was isolated and qRT-PCR
was performed using NRGN specific primers and probe and results were normalized to RPLPO control. Fold change was calculated using
uninfected/mock infected PBMC controls. (D) Immunoblot of NRGN to measure the protein level in PBMC infected with HIV-1 virus or mock. Gag-
p24, represents infectivity; and Actin, represents loading control. (E) Densitometry was performed to quantitate the fold change in signal intensity
compared to uninfected (NT) and normalized with Actin level. NT, uninfected control; NL4-3, CXCR4 coreceptor virus; and YU2, CCR5
coreceptor virus.
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uninfected (MEU) subjects indicate that HIV-1 infection
and/or virus exposure resulted in signature miRNA ex-
pression profile further supports the role of HIV-1 in-
duced miRNA regulation [41,46,48].
Although a number of commonly dysregulated
miRNAs were noted in these studies, there is also a
greater degree of variation between these studies includ-
ing the current study [46,48]. The differences observed
between these studies could be due to a number of rea-
sons including array platforms, the patient population,
sample size, software used and type of analyses, cut-off
set by each group and selection criteria of study subjects.
Our study has a large sample size (n = 30 or more) and
all of our LVL donors were receiving Highly Active Anti-
retroviral Therapy (HAART) and had no or undetectable
viral load for more than 5 years prior to sample collec-
tion. Another possible explanation is the cell types used
in these studies (total PBMC vs. purified CD4+ T cells),
as these are known to exhibit distinct cell specific
miRNA profiles [65,66]. It is also important to point out
that our HVL group has very low CD4+ T cell count
(<200 cells), suggesting that the differentially regulated
miRNAs could be the result of non CD4+ T cell types in
response to HIV-1 infection.
Results from our analyses identified several miRNA
that are uniquely regulated by HIV-1; however the func-
tional consequences of many of these miRNAs are not
fully understood. Further analyses on cell specific
miRNAs expressed during virus replication suggest a
role for miR-132, -125b, -155, -150, -223 -382 and Let-7
in CD4+ T cells [67-69] and miR-198, -28-3P, 125b, -198,
-223 and -382 in monocytes/macrophages [40,70,71],
respectively. In our analyses using PBMCs, we noted dif-
ferential regulation of miR-132, Let-7, -28-3P, -125b, -223,
-382, but no difference in others. Additionally, miRNAs
(miR-214, -223, 132, -128, -150, -32, 24, -93, -198, -296,
351 and -17-92 cluster) are known to target viral RNA
and possess antiviral activity and innate immune functions
[72,73]. Among these miRNAs, miR-214 and miR-223 are
significantly down regulated in HVL subjects, whereas
miR-32, miR-198, miR-128, miR-150 and miR-15 did not
show any change. MiR-146a has been linked to innate
immunity and immune activation [74,75] and miR-155
is involved in T cell proliferation and Treg regulation
[76,77]. These miRNAs are significantly upregulated
in HVL subjects compared to seronegative and LVL
subjects, suggesting that inflammatory factors are
highly upregulated in subjects with HVL supporting
hyper activation of immune cells during AIDS. Our
studies have shown that the LVL group is similar to
the uninfected controls at the mRNA level as evident
in few gene interactions in the STRING pathway
analysis of the mRNA array data similar to previous
studies [42]. On the other hand, several host cellular
pathways and networks including cytokine and che-
mokine interactions, signaling pathways, IFN induced
genes, metallothionein genes and pro-inflammatory
cytokines were dysregulated in high viral load in
comparison to uninfected controls and low viral load
samples. Although we have highlighted immune cell
related functions in this analyses further analyses in-
dicate that additional pathways such as apoptosis and
cell death are that are distinctly regulated in HVL
subjects compared to LVL and control further
supporting the CD4 loss observed in this group.
Overall, we found only 41 significantly dysregulated
mRNAs between uninfected and LVL and all of these
mRNAs had a fold change of less than 2. Meanwhile, the
comparisons of CT vs. HVL and LVL vs. HVL yielded
309 and 182 significantly regulated probes respectively.
Several of these pathways (IFN signaling, innate re-
sponse, defensins, cytokine/chemokine signaling and T
cell signaling) that are dysregulated in the high viral load
(compared to low viral load), are consistent with the re-
sults of other studies using HIV-1 specific target cell
types [4,42-44,78]. We also noticed APOBEC3G, a cellu-
lar defense factor against retroviruses, to be upregulated
in the presence of infection (CT vs. LVL) and high viral
load (CT vs. HVL), which parallels Rotger et al. and their
finding that the gene is upregulated with increasing viral
load [45]. Although the current study utilized total
PBMC for miRNA and mRNA profiling, the results from
this analysis reflect both the direct and indirect effect of
HIV-1 on miRNA and mRNA expression as well as cap-
turing the dysregulated genes from both monocyte and
T cell lineages. As it is well established that less than 1%
of the cells in total PBMCs are productively infected by
the virus, the significant changes observed here may not
be result of a direct effect of HIV-1 infection, but may
instead be indirect effects. These indirect effects could
be due to nonproductively infected cells, exposure of
virus particles (both defective and replication compe-
tent) to target and non-target cells as well as cellular
and viral factors released from the infected cells that
could affect bystander cell population. Our results show
that it would certainly be worthwhile to perform cell
specific analysis on HIV-1 target cells using a focused
array to assess the effect that infection on the RNA spe-
cies within the individual cell types, but this is beyond
the scope of this manuscript.
To study the interaction between the miRNA and
mRNA, we chose not to simply rely on online inter-
action databases, instead, we elected to use our array
data as a supplement to GroupMiR. Notably, our ana-
lysis has predicted pathway-associated targets for many
miRNAs, suggesting that miRNAs effectively target host
cellular pathways during infection and disease progres-
sion. Although several of the predicted miRNA-mRNA
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pairs showed inverse correlation, we also observed a few
positive correlations in mRNA regulation. Specifically, in
case of inflammatory factors, IL6, CCL2 and CCL8 are
inversely regulated by miR-144, miR-376a, miR-935 and
miR-146a, whereas, in our study both expression of
miR-512-3p-CCL8 and miR-518d-3p-CCL8 are posi-
tively correlated in HVL subjects compared to unin-
fected controls. Most importantly, our studies have
identified several new miRNAs that could potentially
regulate RNA transcripts such as AIF1, ALDH1A1,
NCR3 and NRGN that warrant further research. Though
it is established that the host transcriptome is regulated
by HIV-1, it is not clear how transcription is regulated.
Based on our results, it is possible to predict that one of
the mechanisms that the virus employs is the use of
miRNA, as regulation of a single miRNA could modu-
late multiple mRNAs that belong to specific pathways,
which would be beneficial for the virus.
The presence of high viral load has an impact on sev-
eral mRNA transcripts, however, the effect of other fac-
tors such as CD4 count and nadir CD4 has a significant
negative correlation for IL8; this is consistent with data
in the literature that associates infection with elevated
IL8 [79]. This was not surprising because the nadir CD4
counts for some of the HVL subjects were quite low.
Furthermore, this paralleled Stone et al.’s findings of ele-
vated IL6 in HIV patients after an immune restoration
[80]. We also found significant correlations within LVL
for IL6 and NRGN and CD4. Interestingly, we found no
significant correlations with the level of viral load, indi-
cating that the presence of virus has an effect on produ-
cing differential mRNA expression but the level of the
viral load makes no additional difference. Together these
observations suggest that HIV-1 infection, irrespective of
its severity, has significant impact on host cellular tran-
scripts and gene expression resulting in immune
dysregulation. These findings might provide further ex-
planation on why immune function is never restored
back to normal in HAART treated HIV-1 subjects with
no detectable virus load. Our study of miRNA and
mRNA profiles in individuals infected with low and high
levels of viral load has significant clinical relevance. The
finding of several miRNAs that are specific to a particu-
lar viral load could lead to the use of these miRNAs as
biomarkers for the determination of prognosis of the
disease.
Conclusions
In this study, we have shown that the expression profile
of miRNA and mRNA in HIV-1 infected individuals with
high viral load is very distinct from controls indicating
that gene expression is significantly altered in HIV-1 tar-
get cells in response to virus replication. We also identi-
fied several novel genes whose expression levels vary
significantly in our cohorts, and which have potential as
therapeutic targets. By using a comparative profiling of
miRNA and mRNA simultaneously in these study popu-
lations we are able to predict putative miRNA-mRNA
interactions and a mathematical model to explain the
expression of a given mRNA target in terms of its inter-
action with the miRNAs thought to regulate its expres-
sion. Importantly, we identified several new mRNA
targets (Defensin, Neurogranin, AIF) as well as the
miRNAs that could be involved in regulating their ex-
pression through the miRNA-mRNA interaction. These
findings will open new avenues to target host cellular
factors using RNAi and anti-miRNA technologies to
combat HIV-1.
Methods
Study Population and selection criteria
All donor samples were obtained from the Pittsburgh
site of the Multicenter AIDS Cohort Study. The study
was approved by the Institutional Review Board (IRB) at
the University of Pittsburgh and samples were collected
using informed consent forms according to the Univer-
sity policies. Donor blood was processed by Ficol-
hypaque and PBMCs were stored in RNALater or frozen
in LN2 for further use. The study population comprised
uninfected seronegative controls (N = 36), HIV-1 positive
subjects with low viral load (<40 copies/ml) (N = 32),
and HIV-1 positive subjects with a high viral load
(>50,000 copies/ml) (N = 31) at the time of sample col-
lection. Details of the subjects including age, CD4
counts, nadir CD4 counts, viral load at the time of sam-
ple collection, viral load for the past 5 years and number
of years in ART/HAART are included in Table 5.
MicroRNA profiling and data analysis
Total PBMCs were used for RNA isolation. Total RNA
was isolated using the MirVANA kit (Applied
Biosystems), as suggested by the manufacturer. RNA
quality was determined using the Nanodrop2000 spec-
trophotometer and Bioanalyzer and samples with high
RNA quality (RIN values between 8 and 9.7) were used
for further profiling. The human microRNA microfluidic
card set v3.0 (Applied Biosystems) was used for miRNA
profiling of samples. This set enables quantitation of 768
miRNA in total, which include 754 targets, 4 endogen-
ous controls (MammuU6/U6 snRNA run in quadrupli-
cates, and RNU44, RNU48, and ath-miR-159a run in
duplicates). One μg of RNA was reverse transcribed
using *Taqman microRNA reverse transcription kit (Ap-
plied Biosystems, CA) along with megaplex primer
pools, human pools set v3.0; the resulting PCR product
was loaded on to array cards with Taqman Universal
Master Mix II-No UNG, which were run on *ViiA7
Real-Time PCR system according to manufacturer’s
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protocol as well as standardized protocols developed in
our laboratory.
Initial miRNA expression data was analyzed using in-
tegrated ViiA7 software (Applied Biosystems). Each run
was exported individually using the auto threshold and
was then uploaded to RealTime StatMiner software
(Integromics, PA) for further analysis. Detectability
threshold for miRNA assays was set to Ct value less than
or equal to 36 (as no preamplification step was included)
in more than 25% of all samples in each group. We used
Grubbs’ method to eliminate outliers within technical
replicates and imputed missing Ct values based on an
aggregation to the median. We used the Genorm
method to select the endogenous control U6-snRNA/
MammU6 for normalization based on stability scoring
across the samples in each group. The aggregation
method selected was to the median. Differentially
expressed miRNA between different groups were identi-
fied using parametric t-test or LIMMA (one factor ana-
lysis) and were then sorted using the Benjamini-
Hochberg false discovery rate (FDR) method with
adjusted p-values <0.05 and p < 0.01. The fold changes
were obtained using linear RQ values. Hierarchical
clustering for differentially expressed miRNA was
performed with their corresponding dCt values across
the samples in different groups with ‘Complete linkage’
clustering method and ‘Euclidean’ distance measure for
dendrograms.
mRNA profiling and data analysis
For whole genome transcriptome analysis, we used
Illumina HT-12 V4 array bead chips (Illumina, Inc., San
Diego, CA, USA) for mRNA profiling of the different
groups (Control, LVL and HVL) in the study. Each array
targets about 47,231 probes that include 28,688 well-
characterized or annotated coding transcripts along with
11,121 coding transcripts with provisional annotation
and remaining being non-coding transcripts and splice
variants. RNA samples (1μg) were labeled using the
‘TotalPrep RNA’ labeling kit (Ambion), reverse tran-
scribed to cDNA, hybridized onto array bead chips
overnight on rocker and scanned on ‘iScan system’
according to the manufacturer's protocols as well as
standardized protocols developed by the Genomics and
Proteomics Core Laboratories at the University of Pitts-
burgh. Datasets will be deposited in NCBI gene expres-
sion and hybridization array data repository GEO
database.
Statistical analysis
Data analysis was performed using the Illumina
BeadStudio software to delineate the false discovery rate
(FDR) and differences with statistical significance
(p < 0.05). Initial raw data analysis and cubic spline
normalization was done using the BeadStudio Gene
expression module (Illumina, Inc.). The normalized sam-
ple probe profile and control probe profile were then
uploaded to Integrated Biomarker Discovery (IBD)
(Integromics) for further data analysis. A total of 21,852
probe sets were detected in all samples of different
groups (Control, LVL and HVL) with present call filter
set to probes detected in > 75% of samples in each group.
Linear models for microarray data (LIMMA) (one factor
analysis) was used to identify differentially expressed
genes/probes between different groups. These genes
were further sorted based on the Benjamini-Hochberg
false discovery rate (FDR) method with an adjusted
p-value <0.05 and fold change cut-off of at least 2-fold
up/down regulation. Hierarchical clustering for differen-
tially expressed genes/probes was performed using their
corresponding detection signal values across the samples
in different groups with ‘Complete linkage’ clustering
method and ‘Euclidean’ similarity measure for dendro-
grams. Statistical analyses for in vitro experiments and
figures were generated using GraphPad Prism.
Validation of differentially regulated miRNA and mRNA
Based on the data analyses, selected miRNA and mRNA
were verified by qRT-PCR. RNA samples from independ-
ent subjects (n = 5) were used to validate the high through-
put microarray results using miRNA and mRNA specific
primers and probes as suggested by the manufacturer
Table 5 Clinical status, viral load, CD4 counts of subjects used in this study
Parameters Control HIV-1 negative HIV-LVL (HIV-1- low viral load) HIV-HVL (HIV-1 high viral load)
Number per group 36 32 31
Years post SC N/A 6-26 0-11
Age median (range) 50.5 (28-74) 51 (34-62) 42 (28-65)
CD4 count range (time of sample) 385-2194 193-1421 38-378
Nadir CD4 median (range) 562 (240-1074) 259.5 (13-639) 188 (29-469)
Viral load (time of sample collection) N/A <40 46,053-561,627
Viral load variations for past 5 years N/A Remain <40 High
Years on HAART/ART N/A 2-14 0-7
Duskova et al. BMC Infectious Diseases 2013, 13:250 Page 15 of 18
http://www.biomedcentral.com/1471-2334/13/250
(Applied Biosystems). Following normalization to U6
(miRNA) or RPLPO (mRNA), the data were exported and
analyzed in RealTime Statminer software, as suggested by
the manufacturer.
Pathway analysis
To determine gene interactions and correlation net-
works, we used IPA and STRING. The Gene Ontology
Enrichment (GO) analysis tool within IBD was used to
detect biological annotations that are statistically over-
represented in the list of differentially regulated genes/
probes between different groups (e.g. Control and LVL).
With minimum number of overlapping genes equal to 3
and FDR threshold of <0.05, both singular and concur-
rent enrichment analysis were carried out. Significant
terms for biological processes (BP), molecular functions
(MF) and cellular components (CC) were retrieved, ar-
ranged in an order based on p-value for corresponding
term.
Interaction of miRNA-mRNA using GroupMiR
We used GroupMiR [59], a computational method that
integrates miRNA and mRNA expression profiles with
miRNA target prediction databases (which rely on se-
quence analysis), to infer interactions between miRNAs
and their target mRNAs. This approach of combining
expression and sequence analysis has been shown to re-
duce the number of false positives in miRNA target
prediction. We downloaded the predictions from Micro-
Cosm database (http://www.ebi.ac.uk/enright-srv/micro-
cosm/htdocs/targets/v5/) and used these as priors for our
method. We used the default parameters of GroupMiR for
this analysis [59]. The analysis was done with HVL and
LVL samples where paired miRNA and mRNA expression
profiles are available. The log10 ratios of the mRNA ex-
pression levels of HVL/LVL samples to the average values
of control samples were used. For miRNAs, the log10 ra-
tios of the average values of control samples to the dCT
values of HVL/LVL samples were used.
Biological validation of HIV-1 regulated factors in vitro
HIV-1 induced cytokines and chemokines were tested
in an in vitro model by infecting normal donor blood
derived PBMCs infected with CXCR4 - or CCR5 co-
receptor utilizing viruses (NL43 and YU2 respectively)
as described [81,82]. Infection was confirmed via a
HIV-1 p24 ELISA. Seven days post infection, the super-
natant was assessed for the production of CCL2, CCL8,
IL6 and IL8 by ELISA (BD Biosciences, CA) and RNA
and cell lysates from infected cells was assessed for
NRGN by qRT-PCR and western blot, respectively [83].
Additional files
Additional file 1: Table S1. Differentially regulated miRNA in low and
high viral load groups compared to uninfected control group using.
Additional file 2: Figure S1. Hierarchical clustering of miRNAs in HIV-1
infected low viral load (LVL) versus high viral load (HVL) subjects. The
dendogram depicting the clustering of samples is calculated using
Complete linkage with Euclidian distance measure values. Color ranging
from green to red indicates minimum to maximum dCT. Numbers on
Xaxis represent subject group. The clustergrams were generated using
data from StatMiner analyses.
Additional file 3: Table S2. Differentially regulated mRNA probes in
low (LVL) and high viral load (HVL) groups compared to uninfected
control group with statistical significance.
Additional file 4: Figure S2. Hierarchical clustering of differentially
regulated mRNA in low viral load (LVL) ompared to high viral load (HVL)
subjects. The probes in this clustergram are significantly differentially
regulated (p < 0.05). Red indicates high, blue indicates low, and gray
stands for no change in level of expression. Numbers on X-axis represent
subject group; Y-axis represents the gene symbol.
Additional file 5: Table S3. a: Top ten Canonical pathways
representing mRNA that are differentially expressed in LVL group
compared to uninfected seronegative subjects. b: Top ten Canonical
pathways representing mRNA that are differentially expressed in HVL
group compared to uninfected seronegative subjects.
Additional file 6: Figure S3. Network of predicted miRNA-mRNA
interactions by GroupMiR using results from miRNA and mRNA array and
visualized by Cytoscape. Regression-based method was used to predict
the potential miRNA (circles) that actively regulate mRNA (squares).
Differentially regulated miRNA and mRNA in HIV-1 infected subjects
compared to the uninfected controls were used to predict the miRNA-
mRNA pairs. Red and green within the mRNA represents up and down
regulation, respectively. Each slice within the circle represents HIV-1
infected subject.
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